Revvity Inc (RVTY)
Revvity, Inc. is a healthcare company listed on the New York Stock Exchange under the ticker RVTY. The company provides health sciences solutions, technologies, and services across diagnostics, life sciences research, and related applications. Its portfolio includes instruments, reagents, software, subscriptions, detection and imaging technologies, warranties, training, and other services. Revvity also supplies products used in early detection and screening for conditions such as pregnancy, infectious diseases, and a range of genetic, metabolic, and developmental disorders. In addition, the company develops technologies that support genomic workflows and applications in oncology, immunodiagnostics, and drug discovery. Headquartered in Waltham, Massachusetts, Revvity was founded in 1937 and operated previously under the name PerkinElmer, Inc. until its name change in April 2023.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Payment Date | Dividend Yield | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-RVTY
|
$123.93
|
-21.9% Downside
|
Overvalued
|
$147.53
|
-7.1% Downside
|
Fair
|
Good
|
November 13, 2026
|
0.2%
|
74.6x
|
2.5x
|
6.1x
|
17.717 B
|
20.035 B
|
15.9%
|
91.9%
|
6.6
|
13.4%
|
235.1%
|
